CED Digest: 436 Items — March 14, 2026
This CED Digest highlights cannabis compounds fatty liver disease research with 436 clinically relevant items. CBD and CBG show promise in reducing hepatic steatosis and improving metabolic markers. Clinicians gain evidence-based insights into…
Florida Supreme Court Refuses to Review Legalization Lawsuit
The Florida medical cannabis program remains intact as the Supreme Court refuses to review the legalization lawsuit. This decision preserves the state's medical-only cannabis framework. Clinicians must continue operating within existing regulatory…
Georgia House Passes Limited Medical Cannabis Expansion! – Blog
Georgia medical cannabis legislation has recently expanded, marking incremental progress in patient access. This legislation affects physicians and patients by broadening therapeutic options. Clinicians should monitor regulatory updates to understand the…
House Passes Bill to Ease Access to Georgia’s Medical Cannabis Program
The Georgia medical cannabis program is set to expand access with a new bill passed by the House. This legislation aims to ease patient eligibility and broaden therapeutic options. Clinicians should prepare for increased patient counseling related to the…
Georgia House Passes Bill to Expand Medical Cannabis Program
Georgia medical cannabis expansion will increase patient eligibility and require clinicians to update screening and dosing protocols. The new bill reflects evidence-based policy development. Providers should prepare for changes in clinical practice and…
In the Mix: 5 More Articles — March 14, 2026
This article highlights medical cannabis dispensary access expansion and product innovation trends in 2026. It covers regulatory and clinical developments relevant to cannabis clinicians. The focus on medical cannabis dispensary access expansion reflects…
Understanding Virginia’s Recreational Cannabis Regulation Challenges
Virginia recreational cannabis regulation challenges affect clinical counseling and patient education. Clinicians must adapt to evolving policies and uncertain product safety standards. This requires updated intake assessments and proactive patient…
Study Reveals Shift from Illegal to Legal Cannabis in Massachusetts
This study on legal cannabis market dynamics in Massachusetts reveals how legalization affects consumption patterns and product safety. Clinicians gain insights into regulated cannabis product use and related health outcomes. Understanding these dynamics…
Understanding the Texas Hemp Ban and Its Impact on Patients
The texas hemp ban significantly affects patients relying on smokable THC products. Clinicians must counsel patients on alternative delivery methods due to new regulations. Understanding the texas hemp ban helps maintain effective patient care.
In the Mix: 3 More Articles — March 13, 2026
This article discusses the medical cannabis dispensary network expansion and its impact on clinical practice. The focus on regulated cannabis programs highlights growing acceptance in healthcare. Medical cannabis dispensary network expansion is key to…